干细胞领域知识发现平台

[2019-03-15] 科学家鉴定出肝脏中Sox9+双向祖细胞

简介:    2月14日，中国科学院生物化学与细胞生物学研究所周斌研究组在国际学术期刊Stem Cell Reports上发表了题为Lineage Tracing Reveals the Bipotency of SOX9+ Hepatocytes during Liver Regeneration 的最新研究成果。该项工作基于更为精准的遗传谱系示踪系统，利用Sox9-CreER和HNF4a-DreER双同源重组技术特异性标记了Sox9+的肝细胞而非Sox9+的胆管细胞。结合基于双同源重组酶的新型Confetti报告基因小鼠，进行克隆分析实验阐明：单个Sox9+的肝细胞在肝损伤后可以同时产生肝细胞和胆管细胞。该项研究首次证明了Sox9+肝细胞在肝损伤后可作为双向祖细胞同时产生肝细胞和胆管细胞参与肝脏修复和再生。在肝脏稳态情况下，肝细胞更新非常缓慢，而在损伤过程中，肝脏再生能力非常旺盛。肝脏中含有肝脏祖细胞，参与维持肝脏的体内平衡。在损害肝细胞增殖的慢性肝损伤情况下，胆管细胞可以充当干细胞并产生肝细胞参与肝修复再生。此外，肝细胞在某些损伤条件下也可以经历由肝细胞到胆管细胞的转

专利论文项目实验收藏

[2019-03-11] 中科院院长：基因编辑不能因噎废食叫停一切不妥

简介: “基因编辑婴儿事件发生后，国际学术界非常关注，美国科学院、英国皇家学会等单位共同发起了关于该事件的大讨论，并邀请了中国科学院参加，国际科学界对一些问题形成了共识。”9日，全国人大代表、中国科学院院长、党组书记白春礼说，共识包括：就目前而言，在技术不成熟、相应的社会伦理问题未得到充分讨论解决之前，我们应当禁止对于人生殖系基因编辑的临床试验和应用；而对于基础性研究则可以允许科学家尝试探索，否则会影响科技创新的步伐。白春礼认为，生物技术立法应当顺应新兴生产力发展的需求，为生物技术发展保驾护航。“法律的制定要在科学规范、避免误用滥用和鼓励科研探索之间掌握好‘度’，不能‘因噎废食’。”严禁反人类的误用、滥用“除了基因编辑技术，还有辅助生殖技术、克隆技术、器官再造技术等，都对传统的生命伦理观提出了挑战。”白春礼说，无节制地应用，可能会引发生命随机选择、代际混乱、器官商业化、基因歧视等问题。白春礼将此类利用定义为：不法研究对生物技术的反人类利用，任其发展将有可能侵害至高无上的人性尊严和生命价值。“不允许以生殖为目的对人类胚胎或者受精卵进行基因编辑是业界共识，但仅仅靠伦理道德、自我约束会出现有意逃避监

专利论文项目实验收藏

[2019-01-24] Japan’s approval of stem-cell treatment for spinal-cord injury concerns scientists

简介: A stem cell treatment for spinal cord injuries will soon be available in Japan. Credit: Steven Needell/SPLJapan has approved a stem-cell treatment for spinal-cord injuries. The event marks the first such therapy for this kind of injury to receive government approval for sale to patients.“This is an unprecedented revolution of science and medicine, which will open a new era of healthcare,” says oncologist Masanori Fukushima, head of the Translational Research Informatics Center, a Japanese govern

专利论文项目实验收藏

[2018-07-11] Two Excellent Young Researchers Honoured in Heidelberg

简介: Marieke Essers and Theodore Alexandrov have received Chica and Heinz Schaller Award for basic biomedical researchPhoto: Rothe Chica und Heinz Schaller Award for basic biomedical research: Dr Marieke Essers (second from right) and Dr Theodore Alexandrov (centre) receiving the award. The award was handed over by the foundation’s Chairperson, Prof. Dr Rohini Kuner (second from left), Board member Prof. Dr Karoly Nikolich (left) und Prof. Dr Hans-Georg Kräusslich (right), Chairperson of the Scientif

专利论文项目实验收藏

[2018-07-04] DKFZ trainee wins Helmholtz Apprentice Award with a stem cell culture

简介: A great success for one of DKFZ’s young staff members: 22-year old Franziska Pilz came second in the Helmholtz Apprentice Award. The jury commended her for her “significant contribution to the further development of stem cell research and for her independent, proactive and responsible work”. Franziska Pilz who is currently training to be a biology laboratory assistant, worked on a project on the stem cell niche. She accepted her award on April 7.“I’m really delighted and also a little bit proud”

专利论文项目实验收藏

[2018-06-07] European Health Catapult winners named at EIT Health Summit

简介: 06 December 2017The European Health Catapult Competition reached its climax on 5 December at the EIT Health Summit in London, where a jury of experts announced the winning start-ups in the Medtech, Biotech and Digital Health categories.MedtechFollowing a year of training and competition, the top 21 of the original 42 start-ups that were accepted for the prograrmme competed for cash awards and the attention of potential investors at the EIT Health Summit in the European Health Catapult finals. Th

专利论文项目实验收藏

[2018-05-28] BioRN Lounge welcomed Prof. Steffen Rupp from Fraunhofer IGB

简介: Heidelberg, 17.05.2018BioRN Lounge: Prof. Steffen Rupp from Fraunhofer IGB talked about: ”Innate Immunity in 3D-Infection models: From simple Screening Systems to complex Immune Cell supplemented Skin Models”Once again, the BioRN Lounge was the occasion for the life science companies as well for scientists from our research institutes, to meet and chat about latest news and achievements. The BioRN Lounge is the prime monthly networking event for BioRN members. It is the occasion for exchange, me

专利论文项目实验收藏

[2018-04-04] Anemia: When cells fail to produce enough protein factories: Researchers gain new insights into blood cell formation

简介: Every day, stem cells in our bone marrow produce billions of new red blood cells. Any disruption in this process can result in serious disease. Researchers from Charité -- Universitätsmedizin Berlin and Harvard Medical School have succeeded in furthering our understanding of how blood cells are formed. Their insights into the molecular foundations of this process may help break new ground in the treatment of certain types of anemia. The results of this study have been published in Cell.Thanks to

专利论文项目实验收藏

[2018-03-13] BioMed X and Roche announce research collaboration in the field of immunology

简介: BioMed X announced today the initiation of a new research collaboration with F. Hoffmann-La Roche Ltd in the field of immunology. Within the framework of the agreement, BioMed X will launch a global call for applications to establish a new biomedical research group in Heidelberg. The main objective of the new group will be to develop novel approaches for the treatment of several immune-mediated diseases.Myeloid cells are capable of dynamically exerting diverse functions in the immune system, as

专利论文项目实验收藏

[2018-03-13] Roche: European Commission approves Roche’s Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer

简介: Alecensa provides a new treatment option for people with newly diagnosed ALK-positive NSCLCApproval based on phase III ALEX data showing Alecensa reduced the risk of disease progression or death by more than half versus crizotinibRoche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has granted a marketing authorisation for Alecensa® (alectinib) as a monotherapy for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive, advanced

专利论文项目实验收藏

科学仪器

实验动物

实验方案

实验试剂

基因

疾病

细胞器官

方法技术

免疫治疗

发布时间

资讯